Latest Capital Markets News

Silex Systems Limited has announced a $145 million equity raise to fund the commercialisation of its SILEX laser uranium enrichment technology through its US joint venture, Global Laser Enrichment. The capital will support critical technology milestones and expansion into new isotope markets amid a global nuclear fuel renaissance.

Light & Wonder reported a slight revenue dip in Q2 2025 but expanded earnings and margins, fueled by its $850 million Grover acquisition and a strategic shift to a sole ASX listing.

Light & Wonder reported solid Q2 earnings growth and margin expansion despite slight revenue dip, completed Grover acquisition ahead of schedule, and announced plans to delist from Nasdaq for a sole ASX listing by November 2025.

Resolution Minerals has received a non-binding $225 million offer from NASDAQ-listed Snow Lake Resources for its Horse Heaven Project in Idaho, signaling potential major shifts for the company’s US operations.

FBR Limited has locked in a A$20 million share subscription facility with GEM Global Yield LLC, providing flexible capital to advance its innovative robotics platforms and commercialisation efforts.

Alkane Resources has completed its merger with Mandalay Resources, creating a dual-listed gold and antimony producer with a robust growth pipeline and a strong cash position.

Koonenberry Gold Limited reveals promising high-grade gold intercepts at its Enmore Project in NSW and announces a fully funded 10,000m Phase II drilling program to expand its discovery pipeline.

Nimy Resources has appointed NYSE-listed M2i Global to spearhead its US government funding strategy, targeting key grants and loans to advance its gallium projects. This partnership aligns Nimy with critical supply chain initiatives in the United States.

Hot Chili Limited launches a A$14 million rights issue to fund key strategic initiatives, including advancing its La Verde copper-gold discovery and completing asset-level partnering processes within the Costa Fuego Project in Chile.

Imagion Biosystems has raised A$3.5 million through a placement to fund its Phase 2 clinical trial for HER2+ Breast Cancer in the US, marking a significant step in advancing its proprietary MagSense® imaging technology.

Kaiser Reef reports a solid cash boost to $30.7 million driven by strong production from its Henty and A1 gold mines, while clarifying its gold price risk management strategy.

Augustus Minerals has appointed Dr James Warren as its new CEO, bringing a wealth of exploration and corporate growth experience to lead its promising Western Australian projects. This leadership change signals a strategic push towards advancing drilling campaigns and unlocking shareholder value.